MRC1 and carcinosarcoma: All 37 p53abn carcinosarcomas (as diagnosed based on the presence of mutant pattern p53 immunostaining together with wild-type POLE and expression of MMR proteins, that is, MMR proficient) had a TP53 mutation confirmed by sequencing.